XTL Biopharmaceuticals Lt...

NASDAQ: XTLB · Real-Time Price · USD
1.33
-0.09 (-6.34%)
At close: Aug 15, 2025, 1:40 PM
1.41
6.02%
After-hours: Aug 15, 2025, 04:00 PM EDT

XTL Biopharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-13.3 -3.09K -4.89 33.88
PEG Ratio
-0.00 30.93 0.01 -0.2
PS Ratio
30.29 n/a n/a n/a
PB Ratio
2.51 2.48 1.65 2.76
P/FCF Ratio
-8.17 -7.79 -7.32 -14.05
P/OCF Ratio
-8.44 -7.79 -7.32 -14.05
OCF/S Ratio
-3.59 n/a n/a n/a
Debt / Equity Ratio
0.03 n/a n/a n/a
Quick Ratio
0.61 9.93 20.35 27.00
Current Ratio
0.61 9.93 20.35 27.00
Asset Turnover
0.05 n/a n/a n/a
Interest Coverage
-25.26 n/a -80.01 -49.1
Return on Equity
-0.19 n/a -0.34 0.08
Return on Assets
-0.12 n/a -0.32 0.07
Return on Invested Capital
-0.3 -0.34 -0.22 -0.16
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.01 n/a n/a n/a
Net Profit Margin
-2.28 n/a n/a n/a
Pretax Profit Margin
-2.57 n/a n/a n/a
Operating Profit Margin
-4.82 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.06 n/a n/a n/a